Can PSA velocity predict risk of death in men with prostate cancer?

Míreanna comhchosúla

• Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
  de réir: Ulmert, D, et al.
  Foilsithe / Cruthaithe: (2008)
• Testing new PSA subforms to enhance the accuracy of predicting cancer risk and disease outcome in prostate cancer.
  de réir: Lilja, H
  Foilsithe / Cruthaithe: (2008)
• Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
  de réir: Wiklund, F, et al.
  Foilsithe / Cruthaithe: (2009)
• Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
  de réir: O'Brien, M, et al.
  Foilsithe / Cruthaithe: (2009)
• Prostate cancer: estimating the benefits of PSA screening.
  de réir: Vickers, A, et al.
  Foilsithe / Cruthaithe: (2009)